Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Sankyo Aiming for 50% Market Share through Mevalotin, Livalo
September 29, 2003
- Chuikyo Committee Approves Draft Questionnaire on New Medical Technologies
September 29, 2003
- Dear-Doctor Letter Ordered for Intestinal Cleanser Niflec
September 29, 2003
- Hepatitis C Found in 1.6% of People Screened: Survey
September 29, 2003
- REGULATORY NEWS IN BRIEF
September 29, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
September 29, 2003
- NEW PRODUCTS
September 29, 2003
- Nihon Schering Establishing New Research Center in Kobe
September 29, 2003
- Meet the Leaders (25)
September 29, 2003
- Kurume Univ. to Begin Course in Biostatistics
September 29, 2003
- Teva Submits NDA for MAO-B Inhibitor to FDA: Alliance with Eisai
September 22, 2003
- Smoking Increases Medical Costs for COPD: NBI
September 22, 2003
- FDA Approves New Indication for Abilify from BMS, Otsuka
September 22, 2003
- Tanabe Applies for Approval of Research Using Human ES Cells
September 22, 2003
- Alfressa Aims to Be No. 1 Wholesaler with \2 Tril. Sales by 2008
September 22, 2003
- Pathological Aging Must Be Overcome to Achieve Longevity: JPLA Seminar
September 22, 2003
- BUSINESS NEWS IN BRIEF
September 22, 2003
- PRESS SEMINAR
September 22, 2003
- Laserphyrin, Prodif Recommended for Approval
September 22, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
September 22, 2003
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…